Outcomes of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Followed by High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDCT/ASCT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

被引：0
|
作者：
Abdallah, Al-Ola [1 ]
Mohyuddin, Ghulam Rehman [1 ]
Mahmoudjafari, Zahra [2 ]
Shebli, Atrash [3 ]
Kawsar, Hameem [2 ]
Sigle, Monia [2 ]
Shune, Leyla [1 ]
McGuirk, Joseph [1 ]
Ganguly, Siddhartha [1 ]
机构：
[1] Univ Kansas, Med Ctr, Div Hematol Malignancies & Cellular Therapeut, Westwood, KS USA
[2] Univ Kansas, Med Ctr, Westwood, KS USA
[3] Atrium Hlth, Levine Canc Inst, Charlotte, NC USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2020年 / 20卷
关键词：
daratumumab; pomalidomide; relapsed/refractory myeloma; MM;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-235
引用
收藏
页码：S303 / S303
页数：1
相关论文
共 50 条
  • [31] Feasibility of high-dose chemotherapy (HDCT) with doble autologous stem cell transplantation (ASCT) for Ewing and soft tissue sarcomas
    Fernandez Plana, J.
    Lopez Pousa, A.
    Sureda Balari, A.
    Gonzalez Farre, X.
    Paez Lopez-Bravo, D.
    Tibau Martorell, A.
    Perez Altozano, J.
    Lopez Lopez, J.
    Barnadas Molins, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [32] High-dose lenalidomide and melphalan as conditioning for autologous stem cell transplantation in relapsed or refractory multiple myeloma.
    Rossi, Adriana C.
    Monge, Jorge
    Niesvizky, Ruben
    Hsu, Jing Mei
    Shore, Tsiporah
    Van Besien, Koen
    Pearse, Roger
    Mark, Tomer
    Jayabalan, David
    Mayer, Sebastian Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
    Lisenko, Katharina
    Sauer, Sandra
    Bruckner, Thomas
    Egerer, Gerlinde
    Goldschmidt, Hartmut
    Hillengass, Jens
    Schmier, Johann W.
    Shah, Sofia
    Witzens-Harig, Mathias
    Ho, Anthony D.
    Wuchter, Patrick
    BMC CANCER, 2017, 17
  • [34] High-dose therapy followed by autologous haematopoietic stem cell transplantation in multiple myeloma
    Koh, LP
    Linn, YC
    Teoh, G
    Goh, YT
    Tan, PHC
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2002, 31 (06) : 731 - 737
  • [35] High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting
    Katharina Lisenko
    Sandra Sauer
    Thomas Bruckner
    Gerlinde Egerer
    Hartmut Goldschmidt
    Jens Hillengass
    Johann W. Schmier
    Sofia Shah
    Mathias Witzens-Harig
    Anthony D. Ho
    Patrick Wuchter
    BMC Cancer, 17
  • [36] Clinical and quality of life outcomes in patients with multiple sclerosis (MS) after high dose chemotherapy(HDCT) plus autologous stem cell transplantation (ASCT).
    Shevchenko, YL
    Novik, AA
    Afanasiev, BV
    Lisukov, IA
    Fedotov, YN
    Ionova, IT
    Kulagin, AD
    Malysheva, OA
    Bisaga, GN
    Melnichenko, VY
    Chelombit, LV
    Voloshin, SV
    Fedorenko, DA
    Vereschagina, IV
    Kishtovich, AV
    BLOOD, 2004, 104 (11) : 519A - 519A
  • [37] Immune reconstitution after high-dose chemotherapy (HDCT) followed by autologous peripheral stem cell transplantation (PBSCT).
    Reimer, P
    Kunzmann, V
    Weissinger, F
    Wilhelm, M
    BLOOD, 2000, 96 (11) : 402A - 403A
  • [38] Selinexor in Combination with Pomalidomide and Dexamethasone (SPd) for Treatment of Patients with Relapsed Refractory Multiple Myeloma (RRMM)
    Chen, Christine I.
    Bahlis, Nizar J.
    Gasparetto, Cristina
    Tuchman, Sascha A.
    Lipe, Brea
    Baljevic, Muhamed
    Kotb, Rami
    Sutherland, Heather J.
    Bensinger, William I.
    Sebag, Michael
    LeBlanc, Richard
    Venner, Christopher P.
    Schiller, Gary J.
    Lentzsch, Suzanne
    Callander, Natalie S.
    Rossi, Adriana C.
    Sheehan, Heidi
    Van Domelen, Dane
    Kazuharu, Kai
    Wang, Hongwei
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    White, Darrell J.
    BLOOD, 2020, 136
  • [39] Reapplication of High-Dose Chemotherapy and Autologous Blood Stem Cell Transplantation as Salvage Treatment for Patients with Relapsed or Refractory Multiple Myeloma - a Single Center Experience
    Fenk, Roland
    Liese, Vanessa
    Bruns, Ingmar
    Kondakci, Mustafa
    Balleisen, Sebastian
    Saure, Christian
    Schroeder, Thomas
    Haas, Rainer
    Kobbe, Guido
    BLOOD, 2009, 114 (22) : 1327 - 1328
  • [40] Multicenter experience of high dose chemotherapy (HDCT) plus Autologous stem cell transplantation (ASCT) in multiple sclerosis (MS) patients.
    Shevchenko, Yury L.
    Novik, Andrei A.
    Kuznetcov, AlexeyN.
    Afanasiev, Boris V.
    Lisukov, Igor A.
    Rykavicin, Oleg A.
    Myasnikov, Alexandr A.
    Lonova, Tatiana I.
    Shamanski, Sergey V.
    Kulagin, Andrey D.
    Malysheva, Olga A.
    Baziy, Nikolay I.
    Melnichenko, Vladimir Y.
    Fedorenko, Denis A.
    Vereschagina, Inna V.
    Zdorov, Andrey E.
    Kishtovich, Anton V.
    Ivanov, Roman A.
    Fedotov, Yury N.
    Gorodokin, Gary I.
    BLOOD, 2006, 108 (11) : 875A - 875A
12345